Ovarian Cancer or Cancer of the ovary is a disease in which cancer (malignant) cells are found in the ovary. Approximately 25,000 women in the United States are diagnosed with this disease each year.
Genetic marker may predict early onset of prostate cancer – Fox Chase Cancer Center researchers have identified a genetic marker that is associated with an earlier onset of prostate cancer in Caucasian men who have a family history of prostate cancer. If the data are confirmed, the marker may help clinicians personalize prostate cancer screening.
Suit charges that Myriad Genetics BRCA1 and BRCA2 patents interfere with the free flow of information and knowledge in violation of the First Amendment and that human genes are ‘products of nature’ that cannot be patented. – The Association for Molecular Pathology (AMP) announced that it is working with the American Civil Liberties Union (ACLU) and the Public Patent Foundation to bring a lawsuit charging that patents on two human genes associated with breast and ovarian cancer are unconstitutional and should be invalidated.
American Cancer Society awards 143 research grants to investigators at 83 institutions nationwide. Grants total more than $51 million in the second of two cycles for 2009. – The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 143 national research and training grants totaling more than $51 million in the second of two grant cycles for 2009. The grants go into effect beginning July 1, 2009.
Ovarian cancer screening would be feasible in primary care, according to the early results of a major Department of Health, UK funded analysis. – Blood test combined with ultrasound scan can diagnose ovarian cancer (gynecological cancer) early in postmenopausal women, almost 2 years earlier than normal, reported by the British researchers in the Lancet.
Women with BRCA mutation, or worry, most likely to undergo prophylactic mastectomy. Patients’ fear should be strongly considered when counseling women at high risk for breast cancer. – Women at increased risk for breast cancer because of the genetic BRCA mutations are more likely to think a prophylactic mastectomy is the best way to reduce their risk for the disease, compared to other women who are at high risk, according to researchers at The University of Texas M. D. Anderson Cancer Center.
No convincing association is found between use of fertility drugs and risk of ovarian cancer, according to a new study. – The use of fertility drugs does not increase a woman’s risk of developing ovarian cancer, finds a large study from Danish researchers published on bmj.com.
Study links obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. – A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.
Scientists find new genes linked to lung cancer. Discovery opens door to individualized treatment strategies. – Working as part of a multi-institutional collaboration, scientists at Washington University School of Medicine in St. Louis have assembled the most complete catalog to date of the genetic changes underlying the most common form of lung cancer.
Researchers identify protein that fuels ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle. – A protein that stimulates blood vessel growth worsens ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute.
Zydus Cadila has introduced Nudoxa for the treatment of various cancers. One of the critical drugs used in chemotherapy, Nudoxa heralds a new approach in cancer therapy. – Zydus Cadila has introduced an NDDS product ‘Nudoxa’ for the treatment of various cancers. One of the critical drugs used in chemotherapy, Nudoxa heralds a new approach in cancer therapy.
